5 assets in Ureter Small Cell Carcinoma

Therapeutic assets addressing Ureter Small Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Ureter Small Cell Carcinoma	Jonsson Comprehensive Cancer Center	P1	CC (43)
Cis-Diamminedichloroplatinum Ii Ureter Small Cell Carcinoma	Jonsson Comprehensive Cancer Center	P1	CC (43)
Docetaxel Ureter Small Cell Carcinoma	Jonsson Comprehensive Cancer Center	P1	CC (43)
Etoposide Ureter Small Cell Carcinoma	Jonsson Comprehensive Cancer Center	P1	CC (43)
Pembrolizumab Ureter Small Cell Carcinoma	Jonsson Comprehensive Cancer Center	P1	CC (43)